SCHEMBL7001786

SCHEMBL7001786

CC1=C(N)Nc2cc([N+](=O)[O-])ccc2O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.46
ALDH1A1 P00352 5/20 0.46
CYP3A4 P08684 3/20 0.46
TSHR P16473 2/20 0.45
MAPT P10636 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38
CAPN9 O14815 1/20 0.38
CASP3 P42574 1/20 0.38
NR3C1 P04150 1/20 0.37
PGR P06401 1/20 0.37
NR3C2 P08235 1/20 0.37
AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991146 0.88 ALDH1A1 (0.46) TDP1ALDH1A1CYP3A4TSHRMAPT
SCHEMBL8118539 0.87 MAPT (0.40) TDP1ALDH1A1CYP3A4TSHRMAPT
SCHEMBL6995764 0.83 CHRM2 (0.41) TDP1ALDH1A1MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL6992777 0.82 CHRM2 (0.40) TDP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL7002717 0.82 TDP1 (0.42) TDP1ALDH1A1CYP3A4TSHRMAPT
SCHEMBL6991287 0.80 KMT2A (0.44) TDP1ALDH1A1CYP3A4TSHRMAPT
SCHEMBL30867064 0.75 MEN1 (0.57) TDP1ALDH1A1CYP3A4MAPTMEN1
SCHEMBL10650637 0.75 MEN1 (0.57) TDP1ALDH1A1CYP3A4MAPTMEN1
SCHEMBL7002334 0.74 ALDH1A1 (0.41) ALDH1A1CYP3A4TSHRMAPTMEN1
SCHEMBL6999113 0.74 ALDH1A1 (0.46) TDP1ALDH1A1CYP3A4TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed